A phase II study of conventional radiation therapy and thalidomide for supratentorial, newly-diagnosed glioblastoma (RTOG 9806)

Title
A phase II study of conventional radiation therapy and thalidomide for supratentorial, newly-diagnosed glioblastoma (RTOG 9806)
Authors
Keywords
Glioblastoma, Clinical trial, Controlled, Radiation therapy, Thalidomide, Angiogenesis inhibitor
Journal
JOURNAL OF NEURO-ONCOLOGY
Volume 111, Issue 1, Pages 33-39
Publisher
Springer Nature
Online
2012-10-19
DOI
10.1007/s11060-012-0987-0

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation